Aiping Wang
Research Subjects
Aiping Wang has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Dong Jiang
Department of Endocrinology, Nanjing Junxie Hospital, China
3 shared publicationsHui Yang
Department of Endocrinology, Nanjing Junxie Hospital, China
3 shared publicationsLan Liu
3 shared publicationsWei Wang
3 shared publicationsXinjuan Sun
Diabetic Foot Center, The Air Force Hospital of Eastern Theater of PLA, Nanjing, China
3 shared publicationsGai Li
Diabetic Foot Center, The Air Force Hospital of Eastern Theater of PLA, Nanjing, China
2 shared publications
Latest Publications
- Open Access
- 24 October 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1694691
Progress in the clinical application of allogeneic platelet-rich plasma for diabetic foot treatment
Due to peripheral neuropathy and varying degrees of vascular disease, patients with diabetes often suffer from foot ulcers that are challenging to heal and may even progress to gangrene. In recent years, autologous platelet rich plasma (au-PRP) gel has been widely used in the treatment of chronic ulcers, including diabetes foot. However, its limitations have become increasingly evident, such as difficulties in collecting sufficient blood from patients, deficiencies in platelet count and/or function among individuals with diabetes, and high costs associated with individually required equipment. Allogeneic platelet rich plasma (al-PRP) offers similar anti-inflammatory, anti-infective, and growth promoting effects while addressing these drawbacks. Notably, al-PRP can be mass-produced into ready-to-use products, simplifying clinical applications and significantly reducing costs. This article conducted a comprehensive analysis of the application mechanism, necessity, effectiveness and safety, preparation and application methods of al-PRP in the treatment of diabetic foot ulcers, it showed that al-PRP has a promising application prospect in the treatment of diabetic foot.
- 24 October 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1694691
Open AccessProgress in the clinical application of allogeneic platelet-rich plasma for diabetic foot treatment
Due to peripheral neuropathy and varying degrees of vascular disease, patients with diabetes often suffer from foot ulcers that are challenging to heal and may even progress to gangrene. In recent years, autologous platelet rich plasma (au-PRP) gel has been widely used in the treatment of chronic ulcers, including diabetes foot. However, its limitations have become increasingly evident, such as difficulties in collecting sufficient blood from patients, deficiencies in platelet count and/or function among individuals with diabetes, and high costs associated with individually required equipment. Allogeneic platelet rich plasma (al-PRP) offers similar anti-inflammatory, anti-infective, and growth promoting effects while addressing these drawbacks. Notably, al-PRP can be mass-produced into ready-to-use products, simplifying clinical applications and significantly reducing costs. This article conducted a comprehensive analysis of the application mechanism, necessity, effectiveness and safety, preparation and application methods of al-PRP in the treatment of diabetic foot ulcers, it showed that al-PRP has a promising application prospect in the treatment of diabetic foot.
- 27 September 2025
- Published by Springer Nature in Endocrine
- Vol. 90 (2) , 367-374
Clinical pathway management of diabetic Charcot neuro-osteoarthropathy
- 27 September 2025
- Published by Springer Nature in Endocrine
- Vol. 90 (2) , 367-374
Clinical pathway management of diabetic Charcot neuro-osteoarthropathy
- Open Access
- 3 January 2025
- Published by Oxford University Press (OUP) in Burns & Trauma
- Vol. 13, tkaf064
Practical guidelines for the prevention and management of diabetic foot disease in China
Diabetic foot (DF) is a prevalent and significant complication of diabetes mellitus. The primary factors that contribute to amputation and mortality in DF patients are multifaceted and include foot deformities, ulcers, ischemia, and potential concurrent infections. To further standardize DF prevention and treatment in China, improve consistency in DF diagnosis and treatment, and promote the development of a specialized tiered care system, the Chinese Burn Association, the Yangtze River Delta Integrated Diabetic Foot Alliance, and the Editorial Committee of the Chinese Journal of Burns and Wound Repair established a multidisciplinary expert team. The team identified clinical issues concerning the diagnosis, treatment, and prevention of DF via the population, interventions, comparisons, outcomes framework, assessed the quality of relevant evidence using the Grading of Recommendations Assessment, Development and Evaluation system, and ultimately formulated a consensus titled “Practical Guidelines for the Prevention and Management of Diabetic Foot Disease in China.” The guidelines include 46 recommendations that address comprehensive medical assessment; internal medical treatments, including treatments related to blood glucose, blood pressure, and blood lipid control; antithrombotic and anti-infection therapy; perioperative risk assessment and management; surgical interventions, such as debridement, vascular reconstruction, and tissue repair; foot disease prevention; multidisciplinary collaboration; and the establishment of a hierarchical diagnosis and treatment system, with the objective of guiding clinical practice for managing DF in China.
- 3 January 2025
- Published by Oxford University Press (OUP) in Burns & Trauma
- Vol. 13, tkaf064
Open AccessPractical guidelines for the prevention and management of diabetic foot disease in China
Diabetic foot (DF) is a prevalent and significant complication of diabetes mellitus. The primary factors that contribute to amputation and mortality in DF patients are multifaceted and include foot deformities, ulcers, ischemia, and potential concurrent infections. To further standardize DF prevention and treatment in China, improve consistency in DF diagnosis and treatment, and promote the development of a specialized tiered care system, the Chinese Burn Association, the Yangtze River Delta Integrated Diabetic Foot Alliance, and the Editorial Committee of the Chinese Journal of Burns and Wound Repair established a multidisciplinary expert team. The team identified clinical issues concerning the diagnosis, treatment, and prevention of DF via the population, interventions, comparisons, outcomes framework, assessed the quality of relevant evidence using the Grading of Recommendations Assessment, Development and Evaluation system, and ultimately formulated a consensus titled “Practical Guidelines for the Prevention and Management of Diabetic Foot Disease in China.” The guidelines include 46 recommendations that address comprehensive medical assessment; internal medical treatments, including treatments related to blood glucose, blood pressure, and blood lipid control; antithrombotic and anti-infection therapy; perioperative risk assessment and management; surgical interventions, such as debridement, vascular reconstruction, and tissue repair; foot disease prevention; multidisciplinary collaboration; and the establishment of a hierarchical diagnosis and treatment system, with the objective of guiding clinical practice for managing DF in China.
- 1 November 2022
- Vol. 53 (6) , 976-980
影响重症糖尿病足患者大截肢手术平面的因素分析
探讨影响重症糖尿病足患者大截肢平面的主要因素。 用病例对照研究的方法,分析2020年7月–2022年7月于东部战区空军医院重症监护室(ICU)住院的重症糖尿病足大截肢患者临床资料,根据截肢平面高低分为经胫腓骨截肢(TT)组和经股骨截肢(TF)组。对患者的临床资料进行相关性分析,并筛选出影响患者大截肢平面的相关因素进行多因素logistic回归分析。 共完整收集48例大截肢患者资料,其中TT组有15例,TF组有33例。TT组伴心脑血管并发症比例低于TF组〔26.67%(4/15)vs. 57.58(19/33),PPPOR)=0.17, 95%可信区间(CI): 0.03~0.91, P=0.038〕。 心脑血管疾病史、血肌酐水平和下肢动脉介入史是影响重症糖尿病足患者手术大截肢平面的主要因素,其中下肢动脉介入史可能是一种独立保护因素。
- 1 November 2022
- Vol. 53 (6) , 976-980
影响重症糖尿病足患者大截肢手术平面的因素分析
探讨影响重症糖尿病足患者大截肢平面的主要因素。 用病例对照研究的方法,分析2020年7月–2022年7月于东部战区空军医院重症监护室(ICU)住院的重症糖尿病足大截肢患者临床资料,根据截肢平面高低分为经胫腓骨截肢(TT)组和经股骨截肢(TF)组。对患者的临床资料进行相关性分析,并筛选出影响患者大截肢平面的相关因素进行多因素logistic回归分析。 共完整收集48例大截肢患者资料,其中TT组有15例,TF组有33例。TT组伴心脑血管并发症比例低于TF组〔26.67%(4/15)vs. 57.58(19/33),PPPOR)=0.17, 95%可信区间(CI): 0.03~0.91, P=0.038〕。 心脑血管疾病史、血肌酐水平和下肢动脉介入史是影响重症糖尿病足患者手术大截肢平面的主要因素,其中下肢动脉介入史可能是一种独立保护因素。
- Open Access
- 29 October 2022
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 15, 3347-3359
Machine Learning Models for Predicting the Risk of Hard-to-Heal Diabetic Foot Ulcers in a Chinese Population
Background: Early detection of hard-to-heal diabetic foot ulcers (DFUs) is vital to prevent a poor prognosis. The purpose of this work was to employ clinical characteristics to create an optimal predictive model of hard-to-heal DFUs (failing to decrease by > 50% at 4 weeks) based on machine learning algorithms. Methods: A total of 362 DFU patients hospitalized in two tertiary hospitals in eastern China were enrolled in this study. The training dataset and validation dataset were split at a ratio of 7:3. Univariate logistic analysis and clinical experience were utilized to screen clinical characteristics as predictive features. The following six machine learning algorithms were used to build prediction models for differentiating hard-to-heal DFUs: support vector machine, the naïve Bayesian (NB) model, k-nearest neighbor, general linear regression, adaptive boosting, and random forest. Five cross-validations were employed to realize the model’s parameters. Accuracy, precision, recall, F1-scores, and AUCs were utilized to compare and evaluate the models’ efficacy. On the basis of the best model identified, the significance of each characteristic was evaluated, and then an online calculator was developed. Results: Independent predictors for model establishment included sex, insulin use, random blood glucose, wound area, diabetic retinopathy, peripheral arterial disease, smoking history, serum albumin, serum creatinine, and C-reactive protein. After evaluation, the NB model was identified as the most generalizable model, with an AUC of 0.864, a recall of 0.907, and an F1-score of 0.744. Random blood glucose, C-reactive protein, and wound area were determined to be the three most important influencing factors. A corresponding online calculator was created (https://predicthardtoheal.azurewebsites.net/). Conclusion: Based on clinical characteristics, machine learning algorithms can achieve acceptable predictions of hard-to-heal DFUs, with the NB model performing the best. Our online calculator can assist doctors in identifying the possibility of hard-to-heal DFUs at the time of admission to reduce the likelihood of a dismal prognosis.
- 29 October 2022
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 15, 3347-3359
Open AccessMachine Learning Models for Predicting the Risk of Hard-to-Heal Diabetic Foot Ulcers in a Chinese Population
Background: Early detection of hard-to-heal diabetic foot ulcers (DFUs) is vital to prevent a poor prognosis. The purpose of this work was to employ clinical characteristics to create an optimal predictive model of hard-to-heal DFUs (failing to decrease by > 50% at 4 weeks) based on machine learning algorithms. Methods: A total of 362 DFU patients hospitalized in two tertiary hospitals in eastern China were enrolled in this study. The training dataset and validation dataset were split at a ratio of 7:3. Univariate logistic analysis and clinical experience were utilized to screen clinical characteristics as predictive features. The following six machine learning algorithms were used to build prediction models for differentiating hard-to-heal DFUs: support vector machine, the naïve Bayesian (NB) model, k-nearest neighbor, general linear regression, adaptive boosting, and random forest. Five cross-validations were employed to realize the model’s parameters. Accuracy, precision, recall, F1-scores, and AUCs were utilized to compare and evaluate the models’ efficacy. On the basis of the best model identified, the significance of each characteristic was evaluated, and then an online calculator was developed. Results: Independent predictors for model establishment included sex, insulin use, random blood glucose, wound area, diabetic retinopathy, peripheral arterial disease, smoking history, serum albumin, serum creatinine, and C-reactive protein. After evaluation, the NB model was identified as the most generalizable model, with an AUC of 0.864, a recall of 0.907, and an F1-score of 0.744. Random blood glucose, C-reactive protein, and wound area were determined to be the three most important influencing factors. A corresponding online calculator was created (https://predicthardtoheal.azurewebsites.net/). Conclusion: Based on clinical characteristics, machine learning algorithms can achieve acceptable predictions of hard-to-heal DFUs, with the NB model performing the best. Our online calculator can assist doctors in identifying the possibility of hard-to-heal DFUs at the time of admission to reduce the likelihood of a dismal prognosis.
- Open Access
- 1 January 2021
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 17, 65-71
Growth Promoting Effect of Vacuum Sealing Drainage in the Healing Processes of Diabetic Foot Ulcers
Aim: To explore the growth-promoting effect of vacuum sealing drainage (VSD) during the healing processes of diabetic foot ulcers (DFUs). Methods: From November 2018 to December 2019, 38 patients with unilateral DFUs were enrolled in this retrospective study. All patients were divided into two groups according to the use of VSD or not: the VSD group (n=20) and the control group (n=18). The following parameters were used to evaluate the healing process: changes in the mean areas of the ulcers; healing rate (HR); epithelial hyperplasia and angiogenesis as determined by hematoxylin-eosin staining (HE staining); and expression of CD34, CD68 and VEGF as assessed through immunohistochemistry. Perioperative side effects and complications were also recorded. Results: All patients received follow-up and eventually healed. The mean area of wounds was reduced in the VSD group compared to the control group (1.75± 0.64 cm2 vs 0.88± 0.54 cm2, P=0.031). The mean HR of the ulcers in the VSD group was significantly higher than that in the control group (35.23± 2.87% vs 28.78± 1.09%, P=0.017). HE staining showed that the amount of epithelial hyperplasia and angiogenesis increased significantly after VSD, and the immunohistochemistry results showed that the expression of CD34, CD68 and VEGF increased significantly in the VSD group. Conclusion: VSD could significantly accelerate the wound healing process, probably by enhancing the inflammatory response and promoting granulation and angiogenesis in DFUs.
- 1 January 2021
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 17, 65-71
Open AccessGrowth Promoting Effect of Vacuum Sealing Drainage in the Healing Processes of Diabetic Foot Ulcers
Aim: To explore the growth-promoting effect of vacuum sealing drainage (VSD) during the healing processes of diabetic foot ulcers (DFUs). Methods: From November 2018 to December 2019, 38 patients with unilateral DFUs were enrolled in this retrospective study. All patients were divided into two groups according to the use of VSD or not: the VSD group (n=20) and the control group (n=18). The following parameters were used to evaluate the healing process: changes in the mean areas of the ulcers; healing rate (HR); epithelial hyperplasia and angiogenesis as determined by hematoxylin-eosin staining (HE staining); and expression of CD34, CD68 and VEGF as assessed through immunohistochemistry. Perioperative side effects and complications were also recorded. Results: All patients received follow-up and eventually healed. The mean area of wounds was reduced in the VSD group compared to the control group (1.75± 0.64 cm2 vs 0.88± 0.54 cm2, P=0.031). The mean HR of the ulcers in the VSD group was significantly higher than that in the control group (35.23± 2.87% vs 28.78± 1.09%, P=0.017). HE staining showed that the amount of epithelial hyperplasia and angiogenesis increased significantly after VSD, and the immunohistochemistry results showed that the expression of CD34, CD68 and VEGF increased significantly in the VSD group. Conclusion: VSD could significantly accelerate the wound healing process, probably by enhancing the inflammatory response and promoting granulation and angiogenesis in DFUs.
- 1 July 2020
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 165, 108140
Maggot excretions/secretions promote diabetic wound angiogenesis via miR18a/19a – TSP-1 axis
- 1 July 2020
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 165, 108140
Maggot excretions/secretions promote diabetic wound angiogenesis via miR18a/19a – TSP-1 axis
- Top Cited PapersOpen Access
- 1 June 2020
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 53, 38-42
Cytokine storm intervention in the early stages of COVID-19 pneumonia
- 1 June 2020
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 53, 38-42
Top Cited PapersOpen AccessCytokine storm intervention in the early stages of COVID-19 pneumonia
- Open Access
- 25 April 2019
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 11 (1) , 1-9
Prevalence and clinical characteristics of hypertension and metabolic syndrome in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study
To investigate the prevalence and clinical characteristics of hypertension (HTN) and metabolic syndrome (MetS) in newly diagnosed diabetes with ketosis-onset. A cross-sectional study was adopted in 734 newly diagnosed diabetics including 83 type 1 diabetics with positive islet-associated autoantibodies, 279 ketosis-onset diabetics without islet-associated autoantibodies and 372 non-ketotic type 2 diabetics. The clinical characteristics of HTN and MetS were compared across the three groups, and the risk factors of them were appraised in each group. The prevalence of HTN and MetS were substantially higher in the ketosis-onset diabetics (34.4% for HTN and 58.8% for MetS) than in the type 1 diabetics (15.7% for HTN, P = 0.004; 25.3% for MetS, P < 0.001), but showed no remarkable difference compared with the type 2 diabetics (42.7% for HTN, P = 0.496; 72.3% for MetS, P = 0.079). Furthermore, the risk factors for both HTN and MetS in the ketosis-onset diabetics resembled those in the type 2 diabetics, but significantly different from those in the type 1 diabetics. The prevalence of HTN and MetS in the ketosis-onset diabetics were magnificently higher than in the type 1 diabetics but showed no difference in comparison to the type 2 diabetics. Likewise, the clinical features and risk factors of HTN and MetS in the ketosis-onset diabetes resembled those in the type 2 diabetes but differed from those in the type 1 diabetes. Our findings indicate that ketosis-onset diabetes should be classified into type 2 diabetes rather than idiopathic type 1 diabetes.
- 25 April 2019
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 11 (1) , 1-9
Open AccessPrevalence and clinical characteristics of hypertension and metabolic syndrome in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study
To investigate the prevalence and clinical characteristics of hypertension (HTN) and metabolic syndrome (MetS) in newly diagnosed diabetes with ketosis-onset. A cross-sectional study was adopted in 734 newly diagnosed diabetics including 83 type 1 diabetics with positive islet-associated autoantibodies, 279 ketosis-onset diabetics without islet-associated autoantibodies and 372 non-ketotic type 2 diabetics. The clinical characteristics of HTN and MetS were compared across the three groups, and the risk factors of them were appraised in each group. The prevalence of HTN and MetS were substantially higher in the ketosis-onset diabetics (34.4% for HTN and 58.8% for MetS) than in the type 1 diabetics (15.7% for HTN, P = 0.004; 25.3% for MetS, P < 0.001), but showed no remarkable difference compared with the type 2 diabetics (42.7% for HTN, P = 0.496; 72.3% for MetS, P = 0.079). Furthermore, the risk factors for both HTN and MetS in the ketosis-onset diabetics resembled those in the type 2 diabetics, but significantly different from those in the type 1 diabetics. The prevalence of HTN and MetS in the ketosis-onset diabetics were magnificently higher than in the type 1 diabetics but showed no difference in comparison to the type 2 diabetics. Likewise, the clinical features and risk factors of HTN and MetS in the ketosis-onset diabetes resembled those in the type 2 diabetes but differed from those in the type 1 diabetes. Our findings indicate that ketosis-onset diabetes should be classified into type 2 diabetes rather than idiopathic type 1 diabetes.